288 related articles for article (PubMed ID: 11711002)
1. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
Adelman A
J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
[No Abstract] [Full Text] [Related]
2. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
Deedwania PC
Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
[TBL] [Abstract][Full Text] [Related]
3. [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].
Homma Y
Nihon Rinsho; 2001 Mar; 59 Suppl 3():416-21. PubMed ID: 11347106
[No Abstract] [Full Text] [Related]
4. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
5. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
6. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
Fruchart JC
Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
[No Abstract] [Full Text] [Related]
7. Prevention of coronary heart disease with pravastatin.
Davis DR
N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958
[No Abstract] [Full Text] [Related]
8. Cholesterol-lowering agent in men without CHD.
Millard P; Johnson KH
J Fam Pract; 1996 Mar; 42(3):223-4. PubMed ID: 8636668
[No Abstract] [Full Text] [Related]
9. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
[TBL] [Abstract][Full Text] [Related]
10. Prevention of coronary heart disease with pravastatin.
Samani NJ; de Bono DP
N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957
[No Abstract] [Full Text] [Related]
11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
12. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
13. [Primary and secondary prevention of coronary disease by statins].
Ferrières J
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
15. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
Gotto AM; Kuller LH
Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Tonkin AM; Eckermann S; White H; Friedlander D; Glasziou P; Magnus P; Kirby A; Mulray S; Denton M; Sallaberger M; Hunt D; Simes J;
Am Heart J; 2006 Jun; 151(6):1305-12. PubMed ID: 16781242
[TBL] [Abstract][Full Text] [Related]
17. Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease.
Nag SS; Pearson TA; Ma L; Landsman PB; Cimino A; Vickers FF; Alexander CM; Melin JM
Am J Cardiol; 2005 Apr; 95(7):862-4. PubMed ID: 15781017
[TBL] [Abstract][Full Text] [Related]
18. [Broader indication for treatment with statins; the 'heart protection study'].
Stalenhoef AF; Stuyt PM
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
[TBL] [Abstract][Full Text] [Related]
19. Effect of probucol on elderly hypercholesterolemic patients in the FAST study.
Sawayama Y; Maeda S; Ohnishi H; Okada K; Hayashi J
Fukuoka Igaku Zasshi; 2006 Jan; 97(1):15-24. PubMed ID: 16613215
[TBL] [Abstract][Full Text] [Related]
20. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
